Pre-order Enquiry
Request Free Sample
Global Anti-Neoplastic Pharmaceutical Agents Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16930952 | Publishing Date : 04-Dec-2020 | No. of pages : 111
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Anti-Neoplastic Pharmaceutical Agents Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Anti-Neoplastic Pharmaceutical Agents1.1 Anti-Neoplastic Pharmaceutical Agents Market Overview
1.1.1 Anti-Neoplastic Pharmaceutical Agents Product Scope
1.1.2 Market Status and Outlook
1.2 Global Anti-Neoplastic Pharmaceutical Agents Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2015-2026)
1.4 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Region (2015-2020)
1.5 Global Anti-Neoplastic Pharmaceutical Agents Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026)
1.6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026)
1.6.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026)
1.6.4 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026)
2 Anti-Neoplastic Pharmaceutical Agents Market Overview by Type
2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2015-2020)
2.3 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2021-2026)
2.4 Hormones and Antagonists
2.5 Microorganism Products
2.6 Plant Products
2.7 Antitumor Antibiotics
2.8 Alkylating Agents
2.9 Antimetabolites
2.10 Natural Products
3 Anti-Neoplastic Pharmaceutical Agents Market Overview by Application
3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Application (2015-2020)
3.3 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2021-2026)
3.4 Lung Cancer
3.5 Bladder Cancer
3.6 Breast Cancer
3.7 Cervical Cancer
3.8 Leukemia
3.9 Gynecological Cancer
3.10 Other
4 Global Anti-Neoplastic Pharmaceutical Agents Competition Analysis by Players
4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019)
4.3 Date of Key Manufacturers Enter into Anti-Neoplastic Pharmaceutical Agents Market
4.4 Global Top Players Anti-Neoplastic Pharmaceutical Agents Headquarters and Area Served
4.5 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
4.6 Competitive Status
4.6.1 Anti-Neoplastic Pharmaceutical Agents Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 GlaxoSmithKline plc.
5.1.1 GlaxoSmithKline plc. Profile
5.1.2 GlaxoSmithKline plc. Main Business
5.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.1.4 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.1.5 GlaxoSmithKline plc. Recent Developments
5.2 F. Hoffmann-La Roche Ltd
5.2.1 F. Hoffmann-La Roche Ltd Profile
5.2.2 F. Hoffmann-La Roche Ltd Main Business
5.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.2.5 F. Hoffmann-La Roche Ltd Recent Developments
5.3 Eli Lilly and Company
5.5.1 Eli Lilly and Company Profile
5.3.2 Eli Lilly and Company Main Business
5.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.3.4 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.3.5 Bristol-Myers Squibb Company Recent Developments
5.4 Bristol-Myers Squibb Company
5.4.1 Bristol-Myers Squibb Company Profile
5.4.2 Bristol-Myers Squibb Company Main Business
5.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.4.5 Bristol-Myers Squibb Company Recent Developments
5.5 Becton, Dickinson and Company
5.5.1 Becton, Dickinson and Company Profile
5.5.2 Becton, Dickinson and Company Main Business
5.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.5.4 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.5.5 Becton, Dickinson and Company Recent Developments
5.6 Pfizer Inc.
5.6.1 Pfizer Inc. Profile
5.6.2 Pfizer Inc. Main Business
5.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.6.4 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.6.5 Pfizer Inc. Recent Developments
5.7 Novartis AG
5.7.1 Novartis AG Profile
5.7.2 Novartis AG Main Business
5.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.7.4 Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.7.5 Novartis AG Recent Developments
5.8 AstraZeneca
5.8.1 AstraZeneca Profile
5.8.2 AstraZeneca Main Business
5.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.8.4 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.8.5 AstraZeneca Recent Developments
5.9 Gilead
5.9.1 Gilead Profile
5.9.2 Gilead Main Business
5.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
5.9.4 Gilead Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) & (2015-2020)
5.9.5 Gilead Recent Developments
6 North America
6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anti-Neoplastic Pharmaceutical Agents Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Anti-Neoplastic Pharmaceutical Agents Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Region (2015-2020)
Table 4. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2015-2020)
Table 9. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2021-2026)
Table 11. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2015-2020)
Table 14. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2021-2026)
Table 16. Global Anti-Neoplastic Pharmaceutical Agents Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019)
Table 19. Date of Key Manufacturers Enter into Anti-Neoplastic Pharmaceutical Agents Market
Table 20. Global Anti-Neoplastic Pharmaceutical Agents Top Players Headquarters and Area Served
Table 21. Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
Table 22. Global Anti-Neoplastic Pharmaceutical Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. GlaxoSmithKline plc. Basic Information List
Table 25. GlaxoSmithKline plc. Description and Business Overview
Table 26. GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 27. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of GlaxoSmithKline plc. (2015-2020)
Table 28. GlaxoSmithKline plc. Recent Developments
Table 29. F. Hoffmann-La Roche Ltd Basic Information List
Table 30. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 31. F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 32. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of F. Hoffmann-La Roche Ltd (2015-2020)
Table 33. F. Hoffmann-La Roche Ltd Recent Developments
Table 34. Eli Lilly and Company Basic Information List
Table 35. Eli Lilly and Company Description and Business Overview
Table 36. Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 37. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of Eli Lilly and Company (2015-2020)
Table 38. Eli Lilly and Company Recent Developments
Table 39. Bristol-Myers Squibb Company Basic Information List
Table 40. Bristol-Myers Squibb Company Description and Business Overview
Table 41. Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 42. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of Bristol-Myers Squibb Company (2015-2020)
Table 43. Bristol-Myers Squibb Company Recent Developments
Table 44. Becton, Dickinson and Company Basic Information List
Table 45. Becton, Dickinson and Company Description and Business Overview
Table 46. Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 47. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of Becton, Dickinson and Company (2015-2020)
Table 48. Becton, Dickinson and Company Recent Developments
Table 49. Pfizer Inc. Basic Information List
Table 50. Pfizer Inc. Description and Business Overview
Table 51. Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 52. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of Pfizer Inc. (2015-2020)
Table 53. Pfizer Inc. Recent Developments
Table 54. Novartis AG Basic Information List
Table 55. Novartis AG Description and Business Overview
Table 56. Novartis AG Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 57. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of Novartis AG (2015-2020)
Table 58. Novartis AG Recent Developments
Table 59. AstraZeneca Basic Information List
Table 60. AstraZeneca Description and Business Overview
Table 61. AstraZeneca Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 62. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of AstraZeneca (2015-2020)
Table 63. AstraZeneca Recent Developments
Table 64. Gilead Basic Information List
Table 65. Gilead Description and Business Overview
Table 66. Gilead Anti-Neoplastic Pharmaceutical Agents Products, Services and Solutions
Table 67. Revenue (Million US$) in Anti-Neoplastic Pharmaceutical Agents Business of Gilead (2015-2020)
Table 68. Gilead Recent Developments
Table 69. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2015-2020) & (US$ Million)
Table 70. North America Anti-Neoplastic Pharmaceutical Agents Market Size Share by Country (2015-2020)
Table 71. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2015-2020) & (US$ Million)
Table 72. Europe Anti-Neoplastic Pharmaceutical Agents Market Size Share by Country (2015-2020)
Table 73. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2015-2020) & (US$ Million)
Table 74. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size Share by Region (2015-2020) (US$ Million)
Table 75. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2015-2020) & (US$ Million)
Table 76. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size Share by Country (2015-2020) (US$ Million)
Table 77. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Players (2015-2020) (US$ Million)
Table 78. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size Share by Players (2015-2020) (US$ Million)
Table 79. Anti-Neoplastic Pharmaceutical Agents Market Trends
Table 80. Anti-Neoplastic Pharmaceutical Agents Market Drivers
Table 81. Anti-Neoplastic Pharmaceutical Agents Market Challenges
Table 82. Anti-Neoplastic Pharmaceutical Agents Market Restriants
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions: 2020 VS 2026
Figure 4. North America Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type in 2020 & 2026
Figure 10. Hormones and Antagonists Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. Microorganism Products Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. Plant Products Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Antitumor Antibiotics Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Alkylating Agents Market Size (US$ Million) YoY Growth (2015-2026)
Figure 15. Antimetabolites Market Size (US$ Million) YoY Growth (2015-2026)
Figure 16. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application in 2020 & 2026
Figure 17. Lung Cancer Market Size (US$ Million) YoY Growth (2015-2026)
Figure 18. Bladder Cancer Market Size (US$ Million) YoY Growth (2015-2026)
Figure 19. Breast Cancer Market Size (US$ Million) YoY Growth (2015-2026)
Figure 20. Cervical Cancer Market Size (US$ Million) YoY Growth (2015-2026)
Figure 21. Leukemia Market Size (US$ Million) YoY Growth (2015-2026)
Figure 22. Gynecological Cancer Market Size (US$ Million) YoY Growth (2015-2026)
Figure 23. Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Top 5 and Top 10 Players Anti-Neoplastic Pharmaceutical Agents Market Share in 2019
Figure 25. United States Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Canada Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Germany Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. France Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. U.K. Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Italy Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Russia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Nordic Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. South Korea Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Australia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Mexico Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Brazil Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Latin America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Turkey Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. UAE Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Rest of Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Keyplayers in Global Anti-Neoplastic Pharmaceutical Agents Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
GlaxoSmithKline plc.F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead
